Sector Pharmaceuticals & Biotech. - Latest news, views and updates

Pharmaceuticals & Biotech.

SECTOR | 15 Apr 2026

Japanese medical devices firm Create Medic plans to expand India operations

Business Line

Medical devices firm to open sales office in Chennai and other cities; targets 100 crore revenue from the Indian market

Prabhudas Lilladhar released a Sector Update report for Pharmaceuticals & Biotech. on 09 Apr, 2026.

Pharmaceuticals & Biotech.

SECTOR | 15 Apr 2026

Syringe reuse linked to HIV outbreak infecting 331 children in Pakistan

Business Standard

Questions mount over medical oversight in Pakistan after an investigation links unsafe injection practices to a major HIV outbreak among children

Prabhudas Lilladhar released a Sector Update report for Pharmaceuticals & Biotech. on 09 Apr, 2026.

Pharmaceuticals & Biotech.

SECTOR | 15 Apr 2026

Pharma cos brace for soft Q4; US drag persists; domestic growth cushions

Business Standard

Pharma sector may see a 7 per cent Y-o-Y growth in reported sales and a 1 per cent increase in Ebitda, led by steady ex-gRevlimid US sales, healthy domestic growth, and favourable forex movements

Prabhudas Lilladhar released a Sector Update report for Pharmaceuticals & Biotech. on 09 Apr, 2026.

Pharmaceuticals & Biotech.

SECTOR | 09 Apr 2026

Pharma Jan-Mar'26 Earnings Preview Domestic formulations to help mitigate US decline YoY

Pharmaceuticals & Biotech.

Prabhudas Lilladhar

Strong YoY growth expected for LPC, Anthem and TRP Pharmaceutical companies under our coverage are expected to see muted EBITDA growth of ~1% YoY (down ~9% QoQ) in Q4FY26. The primary drag continues to be the elevated base in the US business. However, ex gRevlimid, the core US portfolio should still post growth, suggesting that the underlying base business remains stable. From a profitability standpoint, tailwinds from currency movements will be partly offset by higher freight cost toward the end of quarter, given the Middle East conflict. The relatively benign raw material prices will continue to aid GMs in Q4. The domestic...

Prabhudas Lilladhar released a Sector Update report for Pharmaceuticals & Biotech. on 09 Apr, 2026.

Pharmaceuticals & Biotech.

SECTOR | 04 Apr 2026

Indian Pharma sector clocks $29 billion exports by end of February in FY26

Business Standard

Indian pharmaceutical exports stood at nearly USD 29 billion up to February this financial year registering a growth of five per cent compared to the same period last year, a top official said on Saturday. K Raja Bhanu, Director General, Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) said the sector, currently valued at approximately USD 60 billion, is projected to grow to USD 130 billion by 2030. "Inspite of global challenges, pharmaceuticals exports have been one of the few sectors that has maintained its growth momentum. Pharmaceutical exports during the period AprilFebruary FY26 stood at USD 28.29 billion, reflecting a growth of 5.6 per cent compared to the same period in FY25 led by formulations, biologicals, vaccines and Ayush products," he said. The official further said the exports reached USD 30.47 billion in FY 202425, reflecting a growth of 9.4 percent year on year despite global pricing pressures and trade volatilities..

Prabhudas Lilladhar released a Sector Update report for Pharmaceuticals & Biotech. on 09 Apr, 2026.

Pharmaceuticals & Biotech.

SECTOR | 30 Mar 2026

War in West Asia: Medical device makers call for measures to ease working capital distress'

Business Line

They called for fast-tracking of GST refunds, or a temporary customs duty rebate on the import of raw materials

Prabhudas Lilladhar released a Sector Update report for Pharmaceuticals & Biotech. on 09 Apr, 2026.

Pharmaceuticals & Biotech.

SECTOR | 30 Mar 2026

HLL Lifecare secures ISO 9001:2015 for retail pharmacy operations

Business Standard

HLL Lifecare Limited, a Mini Ratna public sector enterprise under the Union Ministry of Health and Family Welfare, has secured ISO 9001:2015 certification for its retail pharmacy operations. HLL's retail pharmacy network spans 239 centres nationwide, including AMRIT Pharmacies, AMRIT Opticals, HLL Pharmacy & Surgicals, and HLL Opticals, according to a statement on Monday. The certification is expected to bring standardisation, consistency, and greater transparency to HLL's retail operations, strengthening patient trust, the statement said. The achievement comes during a milestone year as HLL celebrates its diamond Jubilee alongside a decade of AMRIT (Affordable Medicines and Reliable Implants for Treatment). The 10th anniversary of AMRIT was commemorated on 15 November in New Delhi and inaugurated by Union Health and Family Welfare Minister J P Nadda, it added. Since its launch in 2015 at AIIMS New Delhi, AMRIT has expanded into a nationwide network covering 24 states and five...

Prabhudas Lilladhar released a Sector Update report for Pharmaceuticals & Biotech. on 09 Apr, 2026.

Pharmaceuticals & Biotech.

SECTOR | 30 Mar 2026

Speciality Medicines IPO: SME stock to list today. Check price band, other details

Economic Times

Speciality Medicines shares debut on the BSE SME platform today. The company's IPO, a fresh issue, sought to raise approximately Rs 29 crore. The price band was set between Rs 117 and Rs 124 per share. Proceeds will fund an R&D centre, international registrations, and marketing. The company operates in speciality pharmaceuticals, with a global presence.

Prabhudas Lilladhar released a Sector Update report for Pharmaceuticals & Biotech. on 09 Apr, 2026.

Pharmaceuticals & Biotech.

SECTOR | 17 Mar 2026, 03:20PM

Speciality Medicines to raise 29 crore via IPO on BSE SME

Business Line

The company will issue 23.50 lakh equity shares at 117-124 each, with the offering opening on March 20

Prabhudas Lilladhar released a Sector Update report for Pharmaceuticals & Biotech. on 09 Apr, 2026.

Pharmaceuticals & Biotech.

SECTOR | 11 Mar 2026

Centre proposes doing away with double testing of blood plasma products

Business Standard

Union Health Ministry moves to remove repeated HIV, Hepatitis tests on pooled plasma to align with global norms and ease compliance while maintaining patient safety

Prabhudas Lilladhar released a Sector Update report for Pharmaceuticals & Biotech. on 09 Apr, 2026.